Modulation of the NF-κB Pathway by Bordetella pertussis Filamentous Hemagglutinin
2008

How Bordetella pertussis Filamentous Hemagglutinin Affects Immune Response

publication 10 minutes Evidence: moderate

Author Information

Author(s): Abramson Tzvia, Kedem Hassy, Relman David A.

Primary Institution: Stanford University School of Medicine

Hypothesis

Does Bordetella pertussis filamentous hemagglutinin (FHA) modulate the NF-κB pathway in host cells?

Conclusion

Prolonged exposure to FHA may inhibit NF-κB activation and compromise the immune response to Bordetella pertussis.

Supporting Evidence

  • FHA induces rapid degradation of IκBα in macrophages but not in epithelial cells.
  • Prolonged exposure to FHA inhibits proteasomal activity and prevents activation of the NF-κB pathway.
  • FHA treatment leads to increased levels of inflammatory cytokines in monocyte-derived cells.

Takeaway

Bordetella pertussis has a part that can trick our immune system. At first, it makes the immune system react, but if it stays too long, it can stop the immune system from working well.

Methodology

The study involved treating human monocytes and macrophages with FHA and measuring NF-κB pathway activation through various assays.

Limitations

The study primarily focused on in vitro models, which may not fully represent in vivo conditions.

Participant Demographics

Human monocytes and macrophages were used in the study.

Statistical Information

P-Value

p<0.000001

Statistical Significance

p<0.000001

Digital Object Identifier (DOI)

10.1371/journal.pone.0003825

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication